Eli Lilly has today forecast annual profit largely above Wall Street estimates, providing some relief to investors after ...

Eli Lilly on Thursday suggested that demand for its popular diabetes and weight-loss treatments was not a concern, easing ...

The company has U.S. offices in Plainsboro, New Jersey. Ellison accused Novo Nordisk, Eli Lilly and Sanofi of inflating ... Donald Trump delayed tariffs on Mexico after his orders to levy tariffs ...

Stay updated on the latest stock market trends and company earnings. Discover the impact of market gains and profit reports ...

Drugmaker Eli Lilly, industrial conglomerate Honeywell International and luxury apparel brand Ralph Lauren are among the prominent companies scheduled to report results before the bell. Amazon.com, ...

In Canada, investors are getting results from Thomson Reuters Corp., BCE Inc., Bombardier Inc., Canada Goose Holdings Inc.

Jim Cramer in a latest program on CNBC reminded viewers about the Trump playbook in the story market and said that he never ...

Bitcoin has fluctuated within a narrow range in recent sessions, reflecting investor caution in an uncertain macroeconomic environment. Along with the heightened trade tensions, the outlook for Fed ...

Jan 14 (Reuters) - Eli Lilly's (LLY.N), opens new tab stock tumbled 8% on Tuesday ... India, Brazil and Mexico was on the company's "to-do list for 2025," Montarce said, without providing further ...

Its new Alzheimer's disease drug, Kisunla, should gain momentum. Trump's tariffs may or may not make Lilly a no-brainer stock in 2025. Still, I think it's a great stock to buy no matter what ...

(Reuters) -Eli ... Lilly also forecast 2025 sales between $58 billion and $61 billion, the midpoint of which is above analysts' estimates of $58.52 billion, helped by the launch of Mounjaro in new ...

Such price increases could directly benefit Eli Lilly by ... continue to grow. Lilly could launch another obesity drug, weight-loss pill orforglipron, in early 2026. Its new Alzheimer's disease ...